Investor Presentation October 2022

Apollo Medical Holdings

October 2022

Built by Doctors.

For Patients.

Forward-looking statements

This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements include any statements about the Company's business, financial condition, operating results, plans, objectives, expectations and intentions, expansion plans, integration of acquired companies and any projections of earnings, revenue, EBITDA, Adjusted EBITDA or other financial items, such as the Company's projected capitation and future liquidity, and may be identified by the use of forward-looking terms such as "anticipate," "could," "can," "may," "might," "potential," "predict," "should," "estimate," "expect," "project," "believe," "plan," "envision," "intend," "continue," "target," "seek," "will," "would," and the negative of such terms, other variations on such terms or other similar or comparable words, phrases or terminology. Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors

described from time to time in the Company's reports to the U.S. Securities and Exchange Commission (the "SEC"), including without

limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, and subsequent Quarterly Reports on Form 10-Q.

Because the factors referred to above could cause actual results or outcomes to differ materially from those expressed or implied in any forward-looking statements, you should not place undue reliance on any such forward-looking statements. Any forward-looking statements speak only as of the date of this presentation and, unless legally required, the Company does not undertake any obligation to update any forward-looking statement, as a result of new information, future events or otherwise.

Key acronyms

ACO: Accountable Care Organization
ACO REACH: Accountable Care Organization Realizing Equity, Access, and Community Health
AIPBP: All-InclusivePopulation-Based Payments
APC: Allied Physicians of California IPA
CMMI: Centers for Medicare and Medicaid Innovation Center
CMS: Centers for Medicare & Medicaid Services
DC: Direct Contracting
DCE: Direct Contracting Entity
DME: Durable Medical Equipment
Health Plan / Payers: Health Insurance Companies
HMO: Health Maintenance Organization
IPA: Independent Practice Association
NCI: Non-Controlling Interest

NMM: Network Medical Management, Inc.
MSA: Master Service Agreement
MSO: Management Services Organization
NGACO: Next Generation Accountable Care Organization
PCP: Primary Care Physician
PMPM: Per Member Per Month
SNF: Skilled Nursing Facility
VIE: Variable Interest Entity

ApolloMed investment highlights

1. Proven model for 25+ years with demonstrable clinical outcomes across all populations

• MA, Managed Medicaid, Commercial, ACA Exchange, Medicare FFS, etc.

2. Large and growing TAM with significant whitespace ahead across market segments (see slide 10)

Focus on aligning with and helping independent providers win

3. • Help them achieve the same scale and outcomes as an integrated delivery system

• Unlocks differentiated independent provider market

4. Proprietary technology platform with data moat, custom built for providers

5. Multiple drivers for growth with a scalable and repeatable playbook led by differentiated leadership team

6. Industry-leading unit economics - growing revenue at 38% YoY(1) profitably while maintaining positive EBITDA margins

(1) ApolloMed YE2021 to mid-point of YE2022E revenue growth

ApolloMed at-a-glance

Apollo Medical Holdings ("ApolloMed") is a leading physician-centric, technology- powered, risk-bearing healthcare company
Our end-to-end technology solutions enable providers to succeed in value-based care arrangements where they "quarterback" patient care to deliver better outcomes
We manage over 1.2M lives through a network of 14 IPAs and 9,800+ contracted physicians, working with 20+ payer partners
We have a 25+ year track record of profitable growth in our core geographic areas and a comprehensive strategy to grow nationally

1.2M+

Managed lives

9,800+

Contracted physicians

66%(1)

Fewer hospital admits per

1,000 vs. benchmark

$186M(2,3)

TTM adj. EBITDA

20+

Payer partners

71%(1)

Fewer ER visits per 1,000 vs. benchmark

$955M(3)

TTM revenue

10-15%

Long-term EBITDA margin

Source: CMS, Chronic Conditions Data Warehouse (CCW), competitors' IR, and internal figures. Internal figures for capitated MA patients

Note: Information as of 12/31/2021 unless otherwise noted; competitor and national information provided is 2019 data unless otherwise noted

Internal Medicare patient data from consolidated IPAs from Jan 2021 - Sept 2021; (2) See "Reconciliation of Net Income to EBITDA and Adjusted EBITDA" and "Use of Non-GAAP Financial Measures" slides for more information; (3) TTM as of 6/30/2022

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Apollo Medical Holdings Inc. published this content on 12 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 October 2022 18:31:45 UTC.